Somaxon Announces FDA Approval Of Silenor(R) (doxepin) For The Treatment Of Insomnia
Links shared publicly online about this topic.
- 1,302total visits
Somaxon Announces FDA Approval Of Silenor(R) (doxepin) For The Treatment Of Insomnia
Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Silenor® (doxepin) for the treatme
View full resource at medicalnewstoday.com
Tags: Sleep Disorder, Sleep, Insomnia, Drug, Pharma, FDA
Most Recently Shared on March 20, 2010 at 11:11 am By:
RT @mnt_sleep: FDA Approval Of Silenor(R) (doxepin) For The Treatment Of Insomnia (Non-addictive!) http://mnt.to/3zcc
Also Shared By:
Somaxon Announces FDA Approval of Silenor (doxepin) for the Treatment of Insomnia
drugs.com — “Silenor (doxepin) is used to treat insomnia characterized by difficulty with sleep maintenance. Includes Silenor side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 23, 2010 at 1:23 am By:
Somaxon Announces FDA Approval of Silenor (doxepin) for the Treatment of Insomnia - http://bit.ly/b7K3PK
Advertisement
medical_tweets
@medical_tweets
Somaxon Announces FDA Approval Of Silenor(R) (doxepin) For The Treatment Of Insomnia Somaxon Pharmaceuticals, Inc. (N.. http://bit.ly/9eRDbZ
1 year ago...